Are Moongipa Capital latest results good or bad?
Moongipa Capital's latest results show strong revenue growth of 76.53% quarter-on-quarter, but profitability has declined sharply, with net profit down 39.79% and operating margins significantly compressed, indicating operational challenges that need to be addressed.
Moongipa Capital Finance's latest financial results for the quarter ended September 2025 present a complex picture of growth and challenges. The company reported net sales of ₹3.76 crores, reflecting a significant increase of 76.53% compared to the previous quarter and a robust year-on-year growth of 92.82%. However, this surge in revenue did not translate into improved profitability. The net profit declined sharply to ₹0.57 crores, marking a decrease of 39.79% from the preceding quarter.A notable concern is the operating profit margin, which contracted dramatically to 22.34% from 64.32% in the previous quarter, indicating substantial cost pressures and operational inefficiencies. This margin compression raises questions about the company's ability to manage its expenses effectively in the current market environment.
The company's return on equity (ROE) stands at 5.82%, which is significantly below the industry average for well-managed non-banking financial companies (NBFCs). This suggests challenges in capital efficiency and profitability, further compounded by a volatile earnings pattern observed over recent quarters.
Additionally, while the company has shown growth in net sales, the overall financial trajectory indicates a troubling inconsistency, with profitability metrics fluctuating significantly. The recent results have led to an adjustment in the company's evaluation, reflecting the ongoing concerns regarding its operational stability and ability to sustain growth.
In summary, while Moongipa Capital Finance has achieved notable revenue growth, the decline in profitability and significant margin compression highlight operational challenges that need to be addressed for the company to improve its financial health and investor confidence.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
